VANCOUVER, British Columbia, Jan. 03, 2023 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the “Company” or “AGN Pharma”) (CSE: AGN) (FRANKFURT: AGW0 ...
The drug repurposing company is researching AP-188 (N,N-Dimethyltryptamine, or DMT) as a potential treatment for the rehabilitation of stroke A novel salt form of a drug is a new and separate ...
NEW YORK, Feb. 3, 2023 /PRNewswire/ -- Terran Biosciences ("Terran"), a biotech platform company dedicated to the development of transformational therapeutics for neurological and psychiatric diseases ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results